Cyclerion Therapeutics (CYCN) News Today $3.16 +0.08 (+2.60%) Closing price 05/21/2026 04:00 PM EasternExtended Trading$3.17 +0.01 (+0.32%) As of 04:11 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CYCN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 Time Period Cyclerion Therapeutics (CYCN) Merges With Korsana Biosciences to Advance Alzheimer’s PipelineApril 21, 2026 | finance.yahoo.comPenny Stock CYCN Surged More Than 300% Yesterday. Why, And Should You Chase the Rally Here?April 2, 2026 | finance.yahoo.comSHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Cyclerion Therapeutics, Inc. (NASDAQ: CYCN)April 2, 2026 | prnewswire.comCyclerion to combine with Korsana Biosciences in $380 million merger dealApril 2, 2026 | msn.comCyclerion provides public listing vehicle for Korsana in $380M dealApril 2, 2026 | bizjournals.comCYCN Stock Alert: Halper Sadeh LLC is Investigating Whether Cyclerion Therapeutics, Inc. is Obtaining a Fair Price for its ShareholdersApril 2, 2026 | businesswire.comShareholder Alert: Ademi LLP investigates whether Cyclerion Therapeutics Inc. is obtaining a Fair Price for Public ShareholdersApril 1, 2026 | prnewswire.comCyclerion Therapeutics, Inc. (CYCN) M&A Call Prepared Remarks TranscriptApril 1, 2026 | seekingalpha.comCYCN stock is soaring 150% pre-market today — what is fueling the rally?April 1, 2026 | msn.comCyclerion Soars Over 160% After Announcing Merger With Korsana Biosciences April 1, 2026 | rttnews.comCyclerion Therapeutics and Korsana Biosciences Announce Merger AgreementApril 1, 2026 | businesswire.comCyclerion Therapeutics (CYCN) price target increased by 100.00% to 8.16February 26, 2026 | msn.comCYCN: Positive Feedback from FDA Sets Stage for Phase 2 Trial of CYC-126 in 2H26February 23, 2026 | finance.yahoo.comCyclerion Therapeutics Announces Progress Toward CYC-126 Phase 2 Proof-of-Concept Study with FDA Feedback and Formation of Clinical Advisory BoardFebruary 17, 2026 | globenewswire.comCYCN: Engineering a reset; initiating coverage of Cyclerion TherapeuticsFebruary 4, 2026 | msn.comCYCN: Engineering a Reset; Initiating Coverage of Cyclerion Therapeutics…February 2, 2026 | finance.yahoo.comMorning Market Brief: Breakthrough Biology Meets Scalable Platforms as Innovators Surge into FocusJanuary 6, 2026 | markets.businessinsider.comCyclerion Therapeutics enters exclusive collaboration with MedsteerJanuary 6, 2026 | msn.comCyclerion Therapeutics stock soars after strategic Medsteer collaborationJanuary 6, 2026 | za.investing.comCyclerion Therapeutics Announces Strategic Agreement with Medsteer and Progress Toward Initiating Phase 2 Proof-of-Concept Study for CYC-126 in Treatment-Resistant DepressionJanuary 5, 2026 | globenewswire.comInsider Stock Buying Reaches US$525.0k On Cyclerion TherapeuticsNovember 11, 2025 | finance.yahoo.comCyclerion Therapeutics Inc.September 30, 2025 | wsj.comCyclerion Therapeutics, Inc. (CYCN) Discusses On Pioneering A New Era In Neuropsychiatric Therapies Call (Transcript)September 24, 2025 | seekingalpha.comCyclerion Therapeutics, Inc. - Pre Recorded Special CallSeptember 24, 2025 | seekingalpha.comCyclerion enters licensing agreement with MIT, announces strategic relaunchSeptember 23, 2025 | msn.comCyclerion Therapeutics Relaunches with Neuropsychiatric FocusSeptember 23, 2025 | msn.comCyclerion stock soars after MIT licensing deal to relaunch companySeptember 23, 2025 | in.investing.comCyclerion Announces Transformational Relaunch as a Neuropsychiatric CompanySeptember 23, 2025 | globenewswire.comCyclerion Therapeutics files $25M mixed securities shelfFebruary 5, 2025 | markets.businessinsider.com3 US Penny Stocks With Market Caps Over $10M To ConsiderFebruary 5, 2025 | finance.yahoo.comLooking Into Cyclerion Therapeutics's Recent Short InterestJanuary 3, 2025 | benzinga.comCyclerion Therapeutics announces update on next stage of growthDecember 18, 2024 | markets.businessinsider.comCyclerion’s sGC Stimulator Portfolio Generates Revenues to Enable Company GrowthDecember 17, 2024 | finance.yahoo.comCyclerion's sGC Stimulator Portfolio Generates Revenues to Enable Company GrowthDecember 17, 2024 | globenewswire.comCyclerion Therapeutics (NASDAQ:CYCN) Stock Quotes, Forecast and News SummaryNovember 16, 2024 | benzinga.comRegina Graul, Ph.D., Promoted to Chief Executive OfficerAugust 7, 2024 | globenewswire.comCYCN Stock Earnings: Cyclerion Therapeutics Reported Results for Q1 2024May 8, 2024 | investorplace.comSage Therapeutics Stock (NASDAQ:SAGE), Quotes and News SummaryApril 28, 2024 | benzinga.comCyclerion Therapeutics Inc Ordinary Shares CYCNApril 21, 2024 | morningstar.comMCYCN Stock Earnings: Cyclerion Therapeutics Reported Results for Q4 2023April 5, 2024 | investorplace.comCyclerion Therapeutics (Nasdaq:CYCN) HeadlineTrading was temporarily halted for "CYCN" at 01:04 PM with a stated reason of "LULD pause."...April 4, 2024 | marketbeat.comCyclerion Therapeutics Inc (CYCN)March 6, 2024 | investing.comCyclerion Therapeutics, Inc. (CYCN)February 29, 2024 | uk.finance.yahoo.comCyclerion Therapeutics (Nasdaq:CYCN) HeadlineTrading was temporarily halted for "CYCN" at 09:02 AM with a stated reason of "LULD pause."...February 26, 2024 | marketbeat.comCyclerion Therapeutics Stock (NASDAQ:CYCN) Dividends: History, Yield and DatesFebruary 23, 2024 | benzinga.comCyclerion Therapeutics (Nasdaq:CYCN) HeadlineTrading was temporarily halted for "CYCN" at 09:12 AM with a stated reason of "LULD pause."...December 20, 2023 | marketbeat.comCyclerion Therapeutics (Nasdaq:CYCN) HeadlineTrading was temporarily halted for "CYCN" at 10:12 AM with a stated reason of "LULD pause."...December 19, 2023 | marketbeat.comCyclerion Therapeutics appoints Graul as PresidentDecember 4, 2023 | msn.comCyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge InnovatorNovember 30, 2023 | finance.yahoo.comCyclerion Therapeutics' Market Cap Drops To US$5.0m Leaving Insiders With LossesNovember 28, 2023 | finance.yahoo.com Get Cyclerion Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CYCN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CYCN Media Mentions By Week CYCN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CYCN News Sentiment▼0.000.40▲Average Medical News Sentiment CYCN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CYCN Articles This Week▼02▲CYCN Articles Average Week Get the Latest News and Ratings for CYCN and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Cyclerion Therapeutics and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies TIL News Today KZR News Today ESLA News Today MGX News Today ZYBT News Today TLPH News Today XLO News Today INCR News Today IXHL News Today ELUT News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CYCN) was last updated on 5/22/2026 by MarketBeat.com Staff. From Our PartnersSystem failure: The strongest leverage for gold…$9 trillion in U.S. debt must be refinanced in 2026 - at current rates - while the largest foreign buyers of T...Golden Portfolio | SponsoredI had never heard of this 1888 accountAn investment account dating back to 1888 has quietly delivered average annual returns of 29% over the last 25...The Oxford Club | Sponsored"Computers are about to become obsolete" - George Gilder. Here’s why.George Gilder predicted the iPhone 16 years early, called Netflix a decade before it dominated streaming, and ...Eagle Publishing | SponsoredSpaceX controls two-thirds of all satellites - and it is about to go publicSpaceX is targeting an IPO on June 11th, with trading set to begin June 12th and the roadshow kicking off June...NXT Wave Research | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredHow to Profit from Elon’s AI lab before it goes publicElon Musk's AI lab has partnered with the Department of Defense, Oracle, and Palantir - and he just filed conf...InvestorPlace | SponsoredI’m sounding the alarmMeta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...Porter & Company | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclerion Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyclerion Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
